Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Capital Reinvestment Ratio
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Capital Reinvestment Ratio of 0.33x as of December 2025, meaning it reinvests 0% of its operating cash flow ($130.31 Million) in capital expenditures ($43.17 Million). See Amneal Pharmaceuticals, Inc. Class A Com (AMRX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Amneal Pharmaceuticals, Inc. Class A Common Stock Capital Reinvestment Ratio (2014–2025)
This chart tracks Amneal Pharmaceuticals, Inc. Class A Common Stock's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Amneal Pharmaceuticals, Inc. Class A Common Stock (2014–2025)
Year-by-year Capital Reinvestment Ratio for Amneal Pharmaceuticals, Inc. Class A Common Stock from 2014 to 2025. For live market cap and broader valuation context, see AMRX market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | $339.99 Million | $70.06 Million | ▼ -18.9% |
| 2024 | 0.25x | $295.10 Million | $74.99 Million | ▲ +26.9% |
| 2023 | 0.20x | $345.58 Million | $69.19 Million | ▼ -85.6% |
| 2022 | 1.39x | $65.10 Million | $90.59 Million | ▲ +605.1% |
| 2021 | 0.20x | $241.82 Million | $47.73 Million | ▲ +21.0% |
| 2020 | 0.16x | $379.00 Million | $61.84 Million | ▼ -99.7% |
| 2019 | 57.14x | $1.71 Million | $97.43 Million | ▲ +14628.1% |
| 2018 | 0.39x | $250.23 Million | $97.09 Million | ▼ -20.5% |
| 2017 | 0.49x | $234.19 Million | $114.27 Million | ▼ -54.9% |
| 2016 | 1.08x | $115.06 Million | $124.61 Million | ▼ -3.2% |
| 2015 | 1.12x | $104.88 Million | $117.38 Million | ▲ +58.3% |
| 2014 | 0.71x | $112.26 Million | $79.38 Million | — |